Abstract
(−)-vibo-Quercitol is a deoxyinositol (1l-1,2,4/3,5-cyclohexanepentol) that occurs naturally in low concentrations in oak species, honeydew honey, and Gymnema sylvestre. The author’s research group recently reported that (−)-vibo-quercitol and scyllo-quercitol (2-deoxy-myo-inositol, 1,3,5/2,4-cyclohexanepentol), a stereoisomer of (−)-vibo-quercitol, are stereoselectively synthesized from 2-deoxy-scyllo-inosose by the reductive reaction of a novel (−)-vibo-quercitol 1-dehydrogenase in Burkholderia terrae and of a known scyllo-inositol dehydrogenase in Bacillus subtilis, respectively. The author’s research group therefore identified two enzymes capable of producing both stereoisomers of deoxyinositols, which are rare in nature. (−)-vibo-Quercitol and scyllo-quercitol are potential intermediates for pharmaceuticals. In this review, the author describes the biosynthesis and enzymatic production of quercitols and myo-inositol stereoisomers and their application in the production of potential pharmaceuticals.
Similar content being viewed by others
Change history
21 September 2018
The published online version contains mistake in the chemical structure of scyllo-inosose in Fig. 5 and Fig. 7. The correct configuration of 1-hydroxyl group in scyllo-inosose should have been the same to myo-inositol.
References
Anderson L (1972) The cyclitols. In: Pigman W, Horton D (eds) The carbohydrates, chemistry and biochemistry. Academic Press, London, pp 520–579
Anderson WA, Magasanik B (1971) The pathway of myo-inositol degradation in Aerobacter aerogenes. Conversion of 2-deoxy-5-keto-d-gluconic acid to glycolytic intermediates. J Biol Chem 246:540–552
Asano N, Kameda Y, Matsui K, Horii S, Fukase H (1990) Validamycin A, new pseudo-tetrasaccharide antibiotic. J Antibiot 43:1039–1041
Bates SH, Jones RB, Bailey CJ (2000) Insulin-like effect of pinitol. Br J Phramacol 130:1944–1948
Carlavilla D, Villamiel M, Martínez-Castro I, Moreno-Arribas V (2006) Occurrence and significance of quercitol and other inositols in wines during oak wood aging. Am J Enol Vitic 57:468–473
Croze ML, Soulage CO (2013) Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95:1811–1827
Daniellou R, Phenix CP, Tam PH, Laliberte MC, Palmer DRJ (2005) Stereoselective oxidation of protected inositol derivatives catalyzed by inositol dehydrogenase from Bacillus subtilis. Org Biomol Chem 3:401–403
Dabhi AS, Bhatt NR, Shah MJ (2013) Voglibose: an alpha glucosidase inhibitor. J Clin Diagn Res 7:3023–3027
Dion HW, Woo PWK, Willmer NE, Kern DL, Onaga J, Fusari SA (1972) Butirosin, a new aminoglycosidic antibiotic complex: isolation and characterization. Antimicrob Ag Chemther 2:84–88
Horii S, Fukase H, Kameda Y (1985) Stereoselective conversion of valienamine and validamine into valiolamine. Carbohydr Res 140:185–200
Itoh N, Isotani K, Nakamura M, Inoue K, Isogai Y, Makino Y (2012) Efficient synthesis of optically pure alcohols by asymmetric hydrogen-transfer biocatalysis: application of engineered enzymes in a 2-propanol-water medium. Appl Microbiol Biotechnol 93:1075–1085
Itoh N, Kurokawa J, Toda H, Konishi K (2017) Identification and characterization of a novel (−)-vibo-quercitol 1-dehydrogenase from Burkholderia terrae suitable for production of (−)-vibo-quercitol from 2-deoxy-scyllo-inosose. Appl Microbiol Biotechnol 101:7545–7555
Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, Nestler JE (2002) Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract 8:417–423
Jiang G, Krishnan HA, Kim YW, Wacek TJ, Krishnan HB (2001) A functional myo-inositol dehydrogenase gene is required for efficient nitrogen fixation and competitiveness of Sinorhizobium fredii USDA191 to nodulate soybean (Glycine max [L.] Merr.). J Bacteriol 183:2595–2604
Kakinuma K, Nango E, Kudo F, Matsushima Y, Eguchi T (2000) An expeditious chemo-enzymatic route from glucose to catechol by the use of 2-deoxy-scyllo-inosose synthase. Tetrahedron Lett 41:1935–1938
Kogure T, Wakisaka N, Takaku H, Takagi M (2007) Efficient production of 2-deoxy-scyllo-inosose from d-glucose by metabolically engineered Escherichia coli. J Biotechnol 129:502–509
Kohler PRA, Zheng JY, Schoffers E, Rossbach S (2010) Inositol catabolism, a key pathway in Sinorhizobium meliloti for competitive host nodulation. Appl Environ Microbiol 76:7972–7980
Kudo F, Numakura M, Tamegai H, Yamamoto H, Eguchi T, Kakinuma K (2005) Extended sequence and functional analysis of the butirosin biosynthetic gene cluster in Bacillus circulans SANK 72073. J Antibiot 58:373–379
Kuno S, Takahashi A, Ogawa S (2011) Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-β-valienamine (NOEV) and N-octyl-β-valienamine (NOV). Bioorg Med Chem Lett 21:7185–7188
Lee D, Lee WS, Lim S, Kim YK, Jung HY, Das S, Lee J, Luo W, Kim KT, Chung SK (2017) A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer’s phenotypes. Sci Rep https://www.ncbi.nlm.nih.gov/pubmed/2907487 7(14125)
Loewus FA, Murthy PPN (2000) myo-Inositol metabolism in plants. Plant Sci 150:1–19
Ma K, Thomason LA, McLaurin J (2012) scyllo-Inositol, preclinical, and clinical data for Alzheimer’s disease. Adv Pharmacol 64:177–212
Majumder AL, Johnson MD, Henry SA (1997) 1l-myo-Inositol-1-phosphate synthase. Biochim Biophys Acta 1348:245–256
Morinaga T, Ashida H, Yoshida K (2010) Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis. Microbiol 156:1538–1546
Miyazawa D, Matsumoto K (2015) Method for producing 2-deoxy-scyllo-inosose. Patent application WO2015005451 A1 (PCT/JP2014/068497).
Ogawa S, Kanto M (2007) Synthesis of valiolamine and some precursors for bioactive carbaglycosylamines from (−)-vibo-quercitol produced by biogenesis of myo-inositol. J Nat Prod 70:493–497
Ogawa S, Uetsuki S, Tezuka Y, Morikawa T, Takahashi A, Sato K (1999) Synthesis and evaluation of glucocerebrosidase inhibitory activity of anhydro deoxyinositols from (+)-epi- and (−)-vibo-quercitols. Bioorg Med Chem Lett 9:1493–1498
Ota Y, Tamegai H, Kudo F, Kuriki H, Koike-Takeshita A, Eguchi T, Kakinuma K (2000) Butirosin-biosynthetic gene cluster from Bacillus circulans. J Antibiot 53:1158–1167
Potawale SE, Shinde VM, Anandi L, Borade S, Dhalawat H, Deshmukh RS (2008) Gymnema sylvestre: a comprehensive review. Pharmacol Online 2:144–157
Ramaley R, Fujita Y, Freese E (1979) Purification and properties of Bacillus subtilis inositol dehydrogenase. J Biol Chem 254:7684–7690
Roscales S, and Plumet J (2016) Biosynthesis and biological activity of carbasugars. Int J Carbohydr Chem ID4760548
Sanz ML, Sanz J, Martínez-Castro I (2004) Presence of some cyclitols in honey. Food Chem 84:133–135
Schlemmer U, Frølich W, Prieto RM, Grases F (2009) Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res 53:S330–S375
Serit M, Okubo T, Su RH, Hagiwara N, Kim M, Iwagata T, Yamamoto T (1991) Antibacterial compounds from oak, Quercus acuta Thunb. Agric Biol Chem 55:19–23
Stein AJ, Geiger JH (2002) The crystal structure and mechanism of 1-l-myo-inositol-1-phosphate synthase. J Biol Chem 277:9484–9491
Takahashi A, Kanbe K, Tamamura T, Sato K (1999) Bioconversion of myo-inositol to rare cyclic sugar alcohols. Anticancer Res 19:3807
Takeuchi M, Takai N, Asano N, Kameda Y, Matsui K (1990) Inhibitory effect of validamine, valienamine and valiolamine on activities of carbohydrases in rat small intestinal brush border membranes. Chem Pharm Bull (Tokyo) 38:1970–1972
Walker JB (1975) myo-Inositol: NAD+ 2-oxidoreductase. In: Hash JH (ed) Methods in enzymology, vol 43. Academic Press, London, pp 433–439
Wacharasindhu S, Worawalai W, Rungprom W, Phuwapraisirisan P (2009) (+)-proto-Quercitol, a natural versatile chiral building block for the synthesis of the α-glucosidase inhibitors, 5-amino-1,2,3,4-cyclohexanetetrols. Tetrahedron Lett 50:2189–2192
Yamaoka M, Osawa S, Morinaga T, Takenaka S, Yoshida K (2011) A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer’s disease. Microb Cell Factories 10:69
Yamauchi N, Kakinuma K (1995) Enzymic carbocycle formation in microbial secondary metabolism. The mechanism of the 2-deoxy-scyllo-inosose synthase reaction as a crucial step in the 2-deoxystreptamine biosynthesis in Streptomyces fradiae. J Org Chem 60:5614–5619
Yebra MJ, Zúniga M, Beaufils S, Perez-Martínez G, Deutscher J, Monedero V (2007) Identification of a gene cluster enabling Lactobacillus casei BL23 to utilize myo-inositol. Appl Environ Microbiol 73:3850–3858
Yoshida K, Yamaguchi M, Morinaga T, Kinehara M, Ikeuchi M, Kinehara M, Ashida H (2006) Genetic modification of Bacillus subtilis for production of d-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome. Appl Environ Microbiol 72:1310–1315
Yoshida K, Yamaguchi M, Morinaga T, Kinehara M, Ikeuchi M, Ashida H, Fujita Y (2008) myo-Inositol catabolism in Bacillus subtilis. J Biol Chem 283:10415–10424
Yoshida K, Sanbongi A, Murakami A, Suzuki H, Takenaka S, Takami H (2012) Three inositol dehydrogenases involved in utilization and interconversion of inositol stereoisomers in a thermophile, Geobacillus kaustophilus HTA426. Microbiology 158:1942–1952
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by the author.
Rights and permissions
About this article
Cite this article
Itoh, N. Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects. Appl Microbiol Biotechnol 102, 4641–4651 (2018). https://doi.org/10.1007/s00253-018-8972-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-018-8972-y